回顾：上周8只新股上市，含1只直接上市公司，如下： MapLight Therapeutics(MPLT)以每股17美元，发行了1475万股，募集了2.51亿美元。 Navan (NAVN) 以每股25美元，发行了3692万股，募集了9.23亿美元。 Boyd Group Services (BGSI) 以每股141，发行了550万股，募集了7.8亿美元。 Nomadar(NOMA)通过直接上市方式，登陆纳斯达克。 SPAC Apex Treasury (APXTU) 、Insight Digital Partners (DYORU)、Dynamix III (DNMXU)、 Viking Acquisition I (VACIU)，分别募集了3亿美元、1.5亿美元、 1.75亿美元、2亿美元。 此外，3家公司递交招股书，其中1家来自中国，为空白招股书。 本周，截至目前暂有6家公司计划上市，具体如下： 1、电动飞机制造商——BETA Technologies, Inc. 计划上市时间：2025年11月4日 交易所：NYSE 股票代码：BETA 该公司计划以每股27至33美元，发行2500万股，拟最高募资约8. ...

Core Points - Evommune, Inc. has filed a registration statement for an initial public offering (IPO) of its common stock, offering 9,375,000 shares at an expected price between $15.00 and $17.00 per share [1] - The company plans to grant underwriters a 30-day option to purchase an additional 1,406,250 shares in connection with the IPO [1] - Evommune's common stock is expected to be listed on the New York Stock Exchange under the symbol "EVMN" [1] - The registration statement is anticipated to become effective on November 5, 2025, allowing the company to price the offering shortly thereafter [1] - Morgan Stanley, Leerink Partners, Evercore ISI, and Cantor are acting as joint book-running managers for the proposed offering [2] Company Overview - Evommune, Inc. is a clinical-stage biotechnology company focused on developing innovative therapies targeting chronic inflammatory diseases [5] - The company's mission is to enhance patients' daily lives and mitigate long-term effects of uncontrolled inflammation caused by existing therapy limitations [5] - Evommune is advancing a portfolio of differentiated product candidates aimed at addressing key drivers of chronic inflammation [5]

EV0301：长效融合蛋白，由IL-18结合蛋白与抗血清白蛋白Fab相关结构域组成，用于治疗特应性皮炎 (AD)和溃疡性结肠炎(UC)。公司计划在2026年启动针对中重度溃疡性结肠炎(UC)患者的二期临床试 验。 由于美国政府持续停摆，Evommune未依赖美国证券交易委员会(SEC)宣布其注册声明生效。根据《证 券法》第8(a)条规定，该公司的注册声明将在提交后20天自动生效。 Evommune成立于2020年。在截至2025年6月30日的12个月内，公司实现营收300万美元。公司计划在纽 约证券交易所(NYSE)上市，股票代码为"EVMN"。摩根士丹利、Leerink Partners、Evercore ISI和康托. 菲茨杰拉德担任此次IPO的联席账簿管理人。公司预计于2025年11月3日当周确定最终发行价。 专注研发慢性炎症性疾病疗法的二期临床阶段生物科技公司Evommune(EVMN.US)于上周五公布了其首 次公开募股(IPO)的发行条款。公司计划通过发行940万股股票筹集1.5亿美元，发行价区间设定为15至 17美元。若按发行价区间中值(16美元)计算，Evommune的市值将达到5.43亿美元 ...

He also leads the investing group IPO Edge , which offers actionable information on growth stocks through first-look IPO filings, previews on upcoming IPOs, an IPO calendar for tracking what’s on the horizon, a database of U.S. IPOs, and a guide to IPO investing to walk you through the entire IPO lifecycle - from filing to listing to quiet period and lockup expiration dates.Analyst’s Disclosure:I/we have no stock, option or similar derivative position in any of the companies mentioned, and no plans to initi ...

Core Insights - The U.S. IPO market remains active despite government shutdown, with 6 traditional IPOs and 2 SPACs launched this week, alongside 13 companies filing for initial public offerings [1][12]. Group 1: IPO Activity - Alliance Laundry Holdings (ALH) raised $826 million, pricing at the upper limit of its range, achieving a market cap of $4.5 billion, and saw a 14% stock price increase [1]. - Phoenix Education Partners (PXED) raised $136 million, pricing at the midpoint of its range, with a market cap of $1.3 billion and a 13% stock price increase [1]. - Ping An Good Doctor (POM) raised $20 million, pricing at the lower limit of its range, with a market cap of $474 million and a 9% stock price increase [2]. - One and One Green Tech (YDDL) raised $10 million, pricing at the midpoint of its range, achieving a market cap of $27 million and a significant 31% stock price increase [2]. - Leifras (LFS) raised $5 million, pricing at the lower limit of its range, with a market cap of $10.5 million, but experienced a 5% stock price decline [2]. - Turn Therapeutics (TTRX) debuted via direct listing at $10, but saw a 26% decline in stock price [3]. Group 2: SPAC Activity - Two SPACs completed their listings: GigCapital8 (GIWWU) raised $220 million and Lake Superior Acquisition (LKSPU) raised $100 million, focusing on energy, social media, and consumer goods [4]. - Five SPACs filed for IPOs, including Xsolla SPAC 1 (XSOLU.RC) and Alussa Energy Acquisition II (ALUBU), both aiming to raise $250 million [8][10]. Group 3: Upcoming IPOs and Market Trends - 13 companies filed for IPOs, including BillionToOne (BLLN), Evommune (EVMN), and Central Bancompany (CBC), each planning to raise $100 million [6]. - The SEC issued new guidelines allowing companies to announce pricing ranges and set final pricing above the range, which may encourage more companies to proceed with listings amid the government shutdown [12].